Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides. Hu Y, Zhu Y, Yu Y, Liu N, et al. Antiviral Res 2023;212:105571.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu Y, Zhu Y, Yu Y, Liu N, et al. Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides. Antiviral Res 2023;212:105571.
PMID: 36868315